90-day dapivirine ring for women's HIV prevention passes its first test in Phase I study
by Microbicide Trials NetworkCredit: CC0 Public DomainIf approved, the monthly dapivirine vaginal ring would be the first biomedical HIV prevention method designed specifically for cisgender women, as
Updated on: March 09,2024
15
90-day dapivirine ring for women's HIV prevention passes its first test in Phase I study
by Microbicide Trials NetworkCredit: CC0 Public DomainIf approved, the monthly dapivirine vaginal ring would be the first biomedical HIV prevention method designed specifically for cisgender women, as
Updated on:March 09,2024
15
